L

Lynn Health Science Institute | Lynn Institute of the Ozarks

Research site
(Unclaimed)
Location
6209 W. 12th Street, Suite B, Little Rock, Arkansas, United States of America
Site insights

Top conditions

Osteoarthritis (5 trials)

Overactive Urinary Bladder (3 trials)

Syndrome (3 trials)

Irritable Bowel Syndrome (3 trials)

Endometriosis (3 trials)

Top treatments

Tanezumab
Diclofenac
K-877
Triglyceride
Fesoterodine
Elagolix
PF-06480605
Ruxolitinib
Tranexamic Acid
Metronidazole

Parent organization

This site is a part of Lynn Health Science Institute

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 40
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 2/3 Study in Adult and Pediatric Participants With SCD

The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of osivelotor.

Enrolling
Sickle Cell Disease
Drug: Osivelotor

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222
Locations recently updated

This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...

Enrolling
Atopic Dermatitis
Drug: Ruxolitinib Cream
Drug: Vehicle Cream

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Enrolling
Obesity
Drug: Placebo
Drug: survodutide

The study was performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care

Active, not recruiting
Uterine Fibroids
Drug: Vilaprisan (BAY1002670)
Other: Standard of care

The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the effi...

Enrolling
Hyperuricemia
Tophi
Drug: Tigulixostat
Drug: Placebo

Trial sponsors

Pfizer logo

Pfizer (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems